相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Effects of PCSK9 Inhibition With Alirocumab on Lipoprotein Metabolism in Healthy Humans
Gissette Reyes-Soffer et al.
CIRCULATION (2017)
Recycling of Apolipoprotein(a) After PlgRKT-Mediated Endocytosis Lipoprotein(a)
Monika Sharma et al.
CIRCULATION RESEARCH (2017)
Thematic Review Series: Lipoprotein (a): Coming of Age at Last Lipoprotein (a): a historical appraisal
Karam M. Kostner et al.
JOURNAL OF LIPID RESEARCH (2017)
Lipoprotein(a): the revenant
Baris Gencer et al.
EUROPEAN HEART JOURNAL (2017)
A Test in Context: Lipoprotein(a) Diagnosis, Prognosis, Controversies, and Emerging Therapies
Sotirios Tsimikas
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Apolipoprotein(a) isoform size, lipoprotein(a) concentration, and coronary artery disease: a mendelian randomisation analysis
Danish Saleheen et al.
LANCET DIABETES & ENDOCRINOLOGY (2017)
The complexity of lipoprotein (a) lowering by PCSK9 monoclonal antibodies
Gilles Lambert et al.
CLINICAL SCIENCE (2017)
Cholesteryl Ester Transfer Protein Inhibition With Anacetrapib Decreases Fractional Clearance Rates of High-Density Lipoprotein Apolipoprotein A-I and Plasma Cholesteryl Ester Transfer Protein
Gissette Reyes-Soffer et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2016)
Estimating the Population Impact of Lp(a) Lowering on the Incidence of Myocardial Infarction and Aortic Stenosis-Brief Report
Mehdi Afshar et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2016)
PCSK9 Association With Lipoprotein(a)
Hagai Tavori et al.
CIRCULATION RESEARCH (2016)
Lipoprotein (a): Coming of Age at Last
Joseph L. Witztum et al.
JOURNAL OF LIPID RESEARCH (2016)
Thematic Review Series: Lipoprotein (a): Coming of Age at Last Structure, function, and genetics of lipoprotein (a)
Konrad Schmidt et al.
JOURNAL OF LIPID RESEARCH (2016)
Lipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology
Borge G. Nordestgaard et al.
JOURNAL OF LIPID RESEARCH (2016)
Distinct metabolism of apolipoproteins (a) and B-100 within plasma lipoprotein(a)
Margaret R. Diffenderfer et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2016)
Complex effects of inhibiting hepatic apolipoprotein B100 synthesis in humans
Gissette Reyes-Soffer et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Effects of Extended-Release Niacin on the Postprandial Metabolism of Lp(a) and ApoB-100-Containing Lipoproteins in Statin-Treated Men With Type 2 Diabetes Mellitus
Esther M. Ooi et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2015)
Anacetrapib lowers LDL by increasing ApoB clearance in mildly hypercholesterolemic subjects
John S. Millar et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Mechanistic insights into Lp(a)-induced IL-8 expression: a role for oxidized phospholipid modification of apo(a)
Corey A. Scipione et al.
JOURNAL OF LIPID RESEARCH (2015)
Lipoprotein(a) metabolism
Stefania Lamon-Fava et al.
CURRENT OPINION IN LIPIDOLOGY (2014)
Absolute quantification of apolipoproteins and associated proteins on human plasma lipoproteins
Anne von Zychlinski et al.
JOURNAL OF PROTEOMICS (2014)
Lipoprotein(a) metabolism: Potential sites for therapeutic targets
Jane Hoover-Plow et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2013)
Genetic Associations with Valvular Calcification and Aortic Stenosis
George Thanassoulis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
In vivo stable-isotope kinetic study suggests intracellular assembly of lipoprotein(a)
Michael E. Frischmann et al.
ATHEROSCLEROSIS (2012)
Optimal therapy for reduction of lipoprotein(a)
G. Lippi et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2012)
Lipoprotein(a): Genotype-Phenotype Relationship and Impact on Atherogenic Risk
Byambaa Enkhmaa et al.
METABOLIC SYNDROME AND RELATED DISORDERS (2011)
Lp(a) lipoprotein enters cultured fibroblasts independently of the plasma membrane low density lipoprotein receptor
Kjell Maartmann-Moe et al.
CLINICAL GENETICS (2010)
Lipoprotein(a) Concentration and the Risk of Coronary Heart Disease, Stroke, and Nonvascular Mortality
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Genetic Variants Associated with Lp(a) Lipoprotein Level and Coronary Disease
Robert Clarke et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
In vivo turnover study demonstrates diminished clearance of lipoprotein(a) in hemodialysis patients
M. E. Frischmann et al.
KIDNEY INTERNATIONAL (2007)
What we have learned about VLDL and LDL metabolism from human kinetics studies
Klaus G. Parhofer et al.
JOURNAL OF LIPID RESEARCH (2006)
Lipoprotein [a] is cleared from the plasma primarily by the liver in a process mediated by apolipoprotein [a]
WJ Cain et al.
JOURNAL OF LIPID RESEARCH (2005)
Effects of the PPARγ agonist pioglitazone on lipoprotein metabolism in patients with type 2 diabetes mellitus
K Nagashima et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
The metabolism of apolipoproteins (a) and B-100 within plasma lipoprotein (a) in human beings
LJ Jenner et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2005)
A new combined multicompartmental model for apolipoprotein B-100 and triglyceride metabolism in VLDL subfractions
M Adiels et al.
JOURNAL OF LIPID RESEARCH (2005)
Structure-function relationships in apolipoprotein(a): insights into lipoprotein(a) assembly and pathogenicity
ML Koschinsky et al.
CURRENT OPINION IN LIPIDOLOGY (2004)
Relationship of non-LDL-bound apo(a), urinary apo(a) fragments and plasma Lp(a) in patients with impaired renal function
E Cauza et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2003)
The metabolism of lipoprotein(a) and other apolipoprotein B-containing lipoproteins: a kinetic study in humans
T Demant et al.
ATHEROSCLEROSIS (2001)
Lipoprotein(a) and coronary heart disease - Meta-analysis of prospective studies
J Danesh et al.
CIRCULATION (2000)
Lipoprotein(a) in homozygous familial hypercholesterolemia
HG Kraft et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2000)
分享论文
